Skip to content
HeyJared

Yaakov Zinberg

Reporter · US

Indexed articles, last 90 days
1
Latest publication
Aug 28, 2026
Outlet visibility, for Chemical & Engineering News
Top 500K sites
Earliest in this view
Aug 28, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 28, 2026 · Yaakov Zinberg, special to C&EN

    As clinical trials surge into Australia, HHS targets US bottlenecks (opens the original)

    Excerpt · English

    Read excerpt

    As clinical trials surge into Australia, HHS targets US bottlenecks US policymakers have proposed reforms in an attempt to replicate Australia’s success in facilitating speedy Phase 1 clinical trials Recurring stories and special news packages from C&EN. CREATE Medicines, a biotech company based in Cambridge, Massachusetts, is developing three cancer medicines that have progressed to Phase 1 clinical trials, typically the first time people receive an experimental drug. Despite the robust biotech

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 500K sites

For Chemical & Engineering News, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Yaakov Zinberg